Cytologic scoring of endometrioid adenocarcinoma of the endometrium: Correlation with histologic grade and clinicopathologic factors

Cancer

Volumn 105, Issue 1, 2005, Pages 8-12

  Nishimura, Yukari ^a   Watanabe, Jun ^a,b,c   Jobo, Toshiko ^a,b   Hattori, Manabu ^a   Arai, Tsutomu ^a   Kuramoto, Hiroyuki ^a,b  

^a KITASATO UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KITASATO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Clinicopathologic factor; Cytologic grade; Cytologic scoring; Endometrial cytology; Endometrioid adenocarcinomas

Indexed keywords

ADENOCARCINOMA; ARTICLE; CANCER GRADING; CYTOLOGY; ENDOMETRIOID CARCINOMA; ENDOMETRIUM; FEMALE; GENE MUTATION; GENITAL TRACT CANCER; HISTOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; PATHOLOGY; PRIORITY JOURNAL; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TUMOR DIFFERENTIATION; UTERUS;

CARCINOMA, ENDOMETRIOID; CELL DIFFERENTIATION; ENDOMETRIAL NEOPLASMS; FEMALE; GENES, P53; HUMANS; MUTATION; NEOPLASM METASTASIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SENSITIVITY AND SPECIFICITY;

EID: 14644390981     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20787     Document Type: Article

References (19)

1. Oshima A, Kuroishi T, Tajima K. Cancer statistics in Japan, 2004.-Mortality, incidence and survival. Tokyo: Shinohara Shinsho, 2004.
2. Nakagawa-Okamura C, Sato S, Tsuji I, et al. Effectiveness of mass screening for endometrial cancer. Acta Cytol. 2002;46: 277-283.
3. Imai M, Jobo T, Sato R, Kawaguchi M, Kuramoto H. Medroxyprogesterone acetate therapy for patients with adenocarcinoma of the endometrium who wish to preserve the uterus-usefulness and limitations. Eur J Gynaecol Oncol. 2001;22:217-220.
4. Gotlieb WH, Beiner ME, Shalmon B, et al. Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer. Obstet Gynecol. 2003;102:718-725.
5. [No authors listed.] FIGO news. Int J Gynecol Obstet. 1989; 28:189-193.
6. Kimura F, Watanabe J, Hata H, et al. PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus. J Cancer Res Clin Oncol. 2003;130:161-168.
7. Hunt CM, Ellis IO, Elston CW, Locker A, Pearson D, Blamey RW. Cytological grading of breast carcinoma - a feasible proposition? Cytopathology. 1990;1:287-295.
8. Taniguchi E, Yang Q, Tang W, et al. Cytologic grading of invasive breast carcinoma. Correlation with clinicopathologic variables and predictive value of nodal metastasis. Acta Cytol. 2000;44:587-591.
9. Taniguchi E, Yoshimura G, Yang Q, et al. Cytologic grade of breast carcinoma [in Japanese with English abstract]. J Jpn Soc Clin Cytol. 2002;41:388-393.
10. Ciatto S, Bonardi R, Herd-Smith A, Cariaggi P, Confortini M, Bulgaresi P. Prognostic value of breast cancer cytologic grading: a retrospective study of 213 cases. Diagn Cytopathol. 1993;9:160-163.
11. Ohno E, Kuramoto H. Diagnosis of the histological grading of endometrial carcinoma by cytology [in Japanese with English abstract]. J Jpn Soc Clin Cytol. 1988;27:449-458.
12. Salvesen HB, Iversen OE, Akslen LA. Prognostic impact of morphometric nuclear grade of endometrial carcinoma. Cancer. 1998;83:956-964.
13. Sorbe B, Risberg B, Thornthwaite J. Nuclear morphometry and DNA flow cytometry as prognostic methods for endometrial carcinoma. Int J Gynecol Cancer. 1994;4:94-100.
14. Van der Putten HW, Baak JP, Koenders TJ, Kurver PH, Stolk HG, Stolte LA. Prognostic value of quantitative pathologic features and DNA content in individual patients with Stage I endometrial adenocarcinoma. Cancer. 1989;63:1378-1387.
15. Jones MW, Kounelis S, Hsu C, et al. Prognostic value of p53 and K-ras-2 topographic genotyping in endometrial carcinoma: a clinicopathologic and molecular comparison. Int J Gynecol Pathol. 1997;16:354-360.
16. Steiner E, Eicher O, Sagemuller J, et al. Multivariate independent prognostic factors in endometrial carcinoma: a clinicopathologic study in 181 patients: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University. Int J Gynecol Cancer. 2003;13:197-203.
17. Oreskovic S, Babic D, Kalafatic D, Barisic D, Beketic-Oreskovic L. A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma. Gynecol Oncol. 2004; 93:34-40.
18. Arnett-Mansfield R, deFazio A, Wain GV, et al. Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium. Cancer Res. 2001;61:4576-4582.
19. Sakaguchi H, Fujimoto J, Bao LH, Nakagawa Y, Tamaya. T. Drastic decrease of progesterone receptor form B but not A mRNA reflects poor patient prognosis in endometrial cancers. Gynecol Oncol. 2004;93:394-399.